Rafael Zago Sá Fortes
Rafael Zago Sá Fortes has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fernanda Gonçalves Salum
Oral Medicine Division Pontifical Catholic University of Rio Grande do Sul‐PUCRS Porto Alegre Brazil
1 shared publication Gillian Luis Andrade Julio
1 shared publicationGuilherme Lobo Speck
De Pesquisa e Ensino Odontológico. ² Especializando em Implantodontia -Instituto IPPO
1 shared publication- Juliana Cassol Spanemberg
Department of Dentistry, Faculty of Health Sciences, Fernando Pessoa Canarias University, Gran Canaria, Spain
1 shared publication - Karen Cherubini
Post-Graduate Program in Dentistry, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90619-900, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 November 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (11) , 2796-2802
Case report of a novel injection molded two-piece ceramic dental implant surgery with immediate loading
This paper aims to briefly review the use of zirconia implants, question the particular indications of these kind of implants and to demonstrate the usage of a novel injection molded two-piece ceramic dental implant from Neodent system (Neodent Zi Implant, Curitiba, Brazil) in a patient presenting a tooth fracture. The implant was performed in a single stage procedure: tooth extraction, implant placement and restoration with a peek abutment and provisional tooth.
- 1 November 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (11) , 2796-2802
Open AccessCase report of a novel injection molded two-piece ceramic dental implant surgery with immediate loading
This paper aims to briefly review the use of zirconia implants, question the particular indications of these kind of implants and to demonstrate the usage of a novel injection molded two-piece ceramic dental implant from Neodent system (Neodent Zi Implant, Curitiba, Brazil) in a patient presenting a tooth fracture. The implant was performed in a single stage procedure: tooth extraction, implant placement and restoration with a peek abutment and provisional tooth.
- Open Access
Adverse Events and Satisfaction Outcomes with Calcium Hydroxylapatite and Polycaprolactone Fillers in Facial Aesthetics: A Systematic Review
Objective: The aim of this study was to systematically review the safety and effectiveness of the injectable biostimulators dermal fillers calcium hydroxyapatite (CaHA) and polycaprolactone (PCL) in facial esthetic procedures. Materials and Methods: Comprehensive electronic searches were executed across six academic databases. The primary outcome focused on safety by examining studies that reported the incidence of adverse events (AEs). The secondary outcome gauged the satisfaction of the patients and injectors by validated esthetic scales. To evaluate biases, the Joanna Briggs Institute Checklist tools were employed. Results: We included a total of 79 studies. In the quantitative assessment of the CaHA, out of 5032 injected patients, 21.8% manifested early AEs, 0.85% experienced delayed reactions, and 0.27% had severe complications. Within the PCL group, consisting of 1119 patients, 83.3% exhibited early AEs, 5.6% had delayed reactions, and none had serious complications. Regarding esthetic satisfaction outcome, both products presented favorable results, but a limited number of studies assessed these data. In the studies evaluated qualitatively, a broad array of AEs were cataloged. Conclusions: The occurrence of serious AEs associated with CaHA and PCL fillers is relatively low. Both CaHA and PCL fillers exhibit favorable safety profiles, with most AEs being transient in nature.
Open AccessAdverse Events and Satisfaction Outcomes with Calcium Hydroxylapatite and Polycaprolactone Fillers in Facial Aesthetics: A Systematic Review
Objective: The aim of this study was to systematically review the safety and effectiveness of the injectable biostimulators dermal fillers calcium hydroxyapatite (CaHA) and polycaprolactone (PCL) in facial esthetic procedures. Materials and Methods: Comprehensive electronic searches were executed across six academic databases. The primary outcome focused on safety by examining studies that reported the incidence of adverse events (AEs). The secondary outcome gauged the satisfaction of the patients and injectors by validated esthetic scales. To evaluate biases, the Joanna Briggs Institute Checklist tools were employed. Results: We included a total of 79 studies. In the quantitative assessment of the CaHA, out of 5032 injected patients, 21.8% manifested early AEs, 0.85% experienced delayed reactions, and 0.27% had severe complications. Within the PCL group, consisting of 1119 patients, 83.3% exhibited early AEs, 5.6% had delayed reactions, and none had serious complications. Regarding esthetic satisfaction outcome, both products presented favorable results, but a limited number of studies assessed these data. In the studies evaluated qualitatively, a broad array of AEs were cataloged. Conclusions: The occurrence of serious AEs associated with CaHA and PCL fillers is relatively low. Both CaHA and PCL fillers exhibit favorable safety profiles, with most AEs being transient in nature.